iShares Russell 2000 ETF Newsroom

Blueprint Medicines (BPMC) Receives a Hold From Morgan Stanley

TipRanks08:41 ET

Barclays Keeps Their Buy Rating on Insmed (INSM)

TipRanks04:19 ET

Analyst Ratings For Abercrombie & Fitch

BenzingaJul 11 09:03 ET

Abercrombie & Fitch Analyst Ratings

BenzingaJul 11 07:48 ET

Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating

MT NewswiresJul 10 11:52 ET

Goldman Sachs Maintains Buy on Insmed, Raises Price Target to $102

BenzingaJul 10 11:27 ET

Goldman Sachs Adjusts Price Target on Sprouts Farmers Market to $89 From $78, Maintains Buy Rating

MT NewswiresJul 10 10:34 ET

FTAI Aviation Downgraded at Wolfe Research

Seeking AlphaJul 10 09:19 ET

Sprouts Farmers Market Analyst Ratings

BenzingaJul 10 08:39 ET

FTAI Aviation Analyst Ratings

BenzingaJul 10 06:18 ET

Insmed Analyst Ratings

BenzingaJul 9 12:24 ET

Truist Financial Sticks to Its Buy Rating for Fluor (FLR)

TipRanksJul 8 22:27 ET

Oppenheimer Adjusts Price Target on Blueprint Medicines to $125 From $114, Maintains Outperform Rating

MT NewswiresJul 8 09:27 ET

HC Wainwright Adjusts Price Target on Insmed to $90 From $70, Maintains Buy Rating

MT NewswiresJul 8 09:27 ET

Blueprint Medicines Analyst Ratings

BenzingaJul 8 08:52 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Insmed (INSM) and Quest Diagnostics (DGX)

TipRanksJul 8 04:43 ET

Insmed (INSM) Receives a Buy From Evercore ISI

TipRanksJul 8 04:34 ET

Insmed Analyst Ratings

BenzingaJul 5 09:22 ET

TD Cowen Sticks to Its Buy Rating for Insmed (INSM)

TipRanksJul 5 07:25 ET

Sprouts Farmers Market Analyst Ratings

BenzingaJul 2 11:54 ET